Your browser doesn't support javascript.
loading
Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues.
Diamanti, Klev; Cavalli, Marco; Pereira, Maria J; Pan, Gang; Castillejo-López, Casimiro; Kumar, Chanchal; Mundt, Filip; Komorowski, Jan; Deshmukh, Atul S; Mann, Matthias; Korsgren, Olle; Eriksson, Jan W; Wadelius, Claes.
Affiliation
  • Diamanti K; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Cavalli M; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Pereira MJ; Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.
  • Pan G; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Castillejo-López C; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Kumar C; Translational Science & Experimental Medicine, Early Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Karolinska Institutet/AstraZeneca Integrated CardioMetabolic Center (KI/AZ ICMC), Department of Medicine, Novum, Huddinge, Sweden.
  • Mundt F; Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Komorowski J; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden; Institute of Computer Science, Polish Academy of Sciences, Warsaw, Poland; Washington National Primate Research Center, Seattle, WA, USA; Swedish Collegium for Advanced Study, Uppsala, Sweden.
  • Deshmukh AS; Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
  • Mann M; Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
  • Korsgren O; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Department of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Eriksson JW; Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.
  • Wadelius C; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. Electronic address: claes.wadelius@igp.uu.se.
Cell Rep Med ; 3(10): 100763, 2022 10 18.
Article in En | MEDLINE | ID: mdl-36198307
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prediabetic State / Diabetes Mellitus, Type 2 Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cell Rep Med Year: 2022 Document type: Article Affiliation country: Suecia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prediabetic State / Diabetes Mellitus, Type 2 Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cell Rep Med Year: 2022 Document type: Article Affiliation country: Suecia Country of publication: Estados Unidos